Fontan Udenafil Exercise Longitudinal Assessment Trial - 2

NCT05918211 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

436

Enrollment

INDUSTRY

Sponsor class

Conditions

Single Ventricle Heart Disease

Interventions

DRUG: Udenafil
DRUG: Placebo

Sponsor

Mezzion Pharma Co. Ltd